J&J helped plan child research institute: report (Tuesday 25th of November 2008 01:53:25 AM)
Esoteric company statistics suggest Johnson & Johnson, maker of the antipsychotic drug
Risperdal, agreed to fund a child psychiatry quest center at Massachusetts General mash unit to
effect data to support use of the drug in children, the Wall Street ...
(more)New Report On NSA Released Today (Saturday 15th of November 2008 12:30:02 AM)
Daveschroeder writes "George command health center has today released a three-volume history of
NSA activities during the Cold War (major highlights). Written by agency historian Thomas R.
Johnson, the 1,000-page report, 'Cryptology During the Cold War, ...
(more)Photoshop Allows Us To Alter Our Memories (Tuesday 19th of August 2008 03:45:01 AM)
Anti-Globalism writes "In an age of digital manipulation, many people believe that snapshots
and family photos need no longer stand as a authoritative record of what was, but instead, of
what they wish it was. It used to be that photographs given documentary ...
(more)Collagen Wrinkle Filler Approved (Friday 04th of July 2008 04:47:57 AM)
HealthDay - THURSDAY, July 3 (HealthDay News) -- The U.S. Food and Drug
Administration has
approved Evolence to treat moderate-to-severe facial
wrinkles and folds, maker Johnson &
Johnson said Wednesday.
More: - Read the rest ...
(more)FDA panel backs proposed J&J psoriasis drug (Wednesday 18th of June 2008 12:12:17 AM)
Johnson & Johnson's
experimental drug ustekinumab should be approved for treating
adults with
reasonable or severe psoriasis, a U.S. advisory panel
unanimously ruled on Tuesday.
More: - Brought to my attention by
...
(more)AIDS Healthcare Foundation criticizes Etravirine's pricing (Tuesday 22nd of January 2008 05:57:00 AM)
AIDS Healthcare root (AHF) has urged Tibotec Pharmaceuticals Ltd., a dividing of Johnson &
Johnson, to reconsider and reduce its steep price for its newest AIDS drug, etravirine (TMC
125), a non-nucleoside reverse transcriptase inhibitor, (NNRTI), which ...
(more)J&J drugs don't work in treating aggression: study (Friday 04th of January 2008 12:02:15 AM)
Two Johnson & Johnson antipsychotic
drugs long used to treat aggressive address in people with
limited intelligence do not work and should not be prescribed
for these patients, researchers
said on Friday.
More: ...
(more)Groups Ask Congress Not To Intervene In CMS Decision On Anemia Drugs (Friday 19th of October 2007 03:00:00 PM)
A fusion of user
antonyms: marketer groups led by the Center for Science in the Public
Interest and Consumers Union on Tuesday in a letter asked Congress not to intervene in a recent
decision by CMS that will limit medicaid coverage for use ...
(more)Microsoft Working On Health Information 'Vault' System (Friday 05th of October 2007 07:45:03 AM)
Josmar52789 wrote with an article from the New York Times, discussing Microsoft's new push into
the merchandiser health care market. The plan is to offer personal health care records online
via a system called HealthVault. Numerous big names in the medical ...
(more)J&J says new stent study results "inconsistent" (Tuesday 04th of September 2007 12:41:43 PM)
Results of a study showing career with
acute heart attacks are more likely to die if given
a
drug-coated stent than a bare metal one are out of line with
other findings, stent maker
Johnson & Johnson said on Tuesday.
...
(more)U.S. OKs J&J drug for 2 mental disorders in children (Thursday 23rd of August 2007 01:51:34 AM)
Johnson & Johnson won U.S. approval
to promote the drug Risperdal for treating
schizophrenia and
bipolar disorder in parturiency and teenagers, officials said on
Wednesday.
More: - Read More
...
(more)
.